HAMILTON, ON, January 24, 2024 / – Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, announces today that the British Columbia Securities Commission (the “BCSC”) has issued a Failure-to-File Cease Trade Order (“FFCTO”) pursuant to National Policy 11-207 – Failure to File Cease Trade Orders and Revocations in Multiple Jurisdictions in respect of the securities of the Company as a result of the Company’s delay to file its:

  1. annual audited financial statements for the year ended June 30, 2023;
  2. interim financial statements for the interim period ended September 30, 2023;
  3. management’s discussion and analysis for the year ended June 30, 2023 and for the interim period ended September 30, 2023; and
  4. certification of annual and interim filings for the year ended June 30, 2023 and for the interim period ended September 30, 2023,

all as required by National Instrument 51-102 – Continuous Disclosure Obligations and National Instrument 52-109 – Certification of Disclosure in Issuers’ Annual and Interim Filings (collectively, the “Documents”).

The Company previously announced that the BCSC had granted a further extension of its Management Cease Trade Order through January 12, 2024. The delay from the Company having the necessary resources to provide all information and support for the financial records required for the auditors to complete its audit and permit filing of the Documents is continuing, and has continued longer than anticipated by the Company.

The Company is actively working with its auditors to address issues raised by its auditors in the audit process, to enable the audit to be completed so the Company can file the Documents as soon as possible, at which point the Company will seek to have the FFCTO revoked and trading reinstated on the TSX Venture Exchange. The Company has appointed a special committee with independent counsel and accounting advice, so that all issues raised are being properly and thoroughly addressed by the Company.   The Company will provide an update via a news release in due course once it has further information on the issues raised by the auditors, and the expected timing of filing the Documents.  The Company also confirms, as of the date of this news release, that there is no other material information concerning the affairs of the Company that has not been generally disclosed.

Reliq Health

Reliq Health Technologies is a rapidly growing global healthcare technology company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits.  Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the Frankfurt Stock Exchange under the WKN: A2AJTB.


“Chris Shields”

Interim CEO

For further information please contact:

Company Contact

Investor Relations at ir@reliqhealth.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws.  All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.

We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the “Company“) does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.